Literature DB >> 7487957

Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.

C Kronman1, B Velan, D Marcus, A Ordentlich, S Reuveny, A Shafferman.   

Abstract

The possible role of post-translational modifications such as subunit oligomerization, protein glycosylation and oligosaccharide processing on the circulatory life-time of proteins was studied using recombinant human acetylcholinesterase (rHuAChE). Different preparations of rHuAChE containing various amounts of tetramers, dimers and monomers are cleared at similar rates from the circulation, suggesting that oligomerization does not play an important role in determining the rate of clearance. An engineered rHuAChE mutant containing only one N-glycosylation site was cleared from the circulation more rapidly than the wild-type triglycosylated enzyme. On the other hand, hyperglycosylated mutants containing either four or five occupied N-glycosylation sites, analagous to those present on the slowly cleared fetal bovine serum acetylcholinesterase (FBS-AChE), were also cleared more rapidly from the bloodstream than the wild-type species. Furthermore, the two different tetraglycosylated mutants were cleared at different rates while the pentaglycosylated mutant exhibited the most rapid clearance profile. These results imply that though the number of N-glycosylation sites plays a role in the circulatory life-time of the enzyme, the number of N-glycan units in itself does not determine the rate of clearance. When saturating amounts of asialofetuin were administered together with rHuAChE, the circulatory half-life of the enzyme was dramatically increased (from 80 min to 19 h) and was found to be similar to that displayed by plasma-derived cholinesterases while desialylation of these enzymes caused a sharp decrease in the circulatory half-life to approximately 3-5 min. Determination of the average number of sialic acid residues per enzyme subunit of the five different N-glycosylation species generated, revealed that the rate of clearance is not a function of the absolute number of appended sialic acid moieties but rather of the number of unoccupied sialic acid attachment sites per enzyme molecule. Specifically, we demonstrate an inverse-linear relationship between the number of vacant sialic acid attachment sites and the values of the enzyme residence time within the bloodstream.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487957      PMCID: PMC1136095          DOI: 10.1042/bj3110959

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  Structures and functions of the sugar chains of glycoproteins.

Authors:  A Kobata
Journal:  Eur J Biochem       Date:  1992-10-15

2.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

Review 3.  Bioprocess factors affecting glycoprotein oligosaccharide structure.

Authors:  C F Goochee
Journal:  Dev Biol Stand       Date:  1992

4.  Interrelations between assembly and secretion of recombinant human acetylcholinesterase.

Authors:  A Kerem; C Kronman; S Bar-Nun; A Shafferman; B Velan
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

5.  The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha.

Authors:  P L Smith; T P Skelton; D Fiete; S M Dharmesh; M C Beranek; L MacPhail; G J Broze; J U Baenziger
Journal:  J Biol Chem       Date:  1992-09-25       Impact factor: 5.157

6.  Structure of the N- and O-glycans of the A-chain of human plasma alpha 2HS-glycoprotein as deduced from the chemical compositions of the derivatives prepared by stepwise degradation with exoglycosidases.

Authors:  H Watzlawick; M T Walsh; Y Yoshioka; K Schmid; R Brossmer
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

Review 7.  Protein glycosylation.

Authors:  K Furukawa; A Kobata
Journal:  Curr Opin Biotechnol       Date:  1992-10       Impact factor: 9.740

8.  Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit.

Authors:  C Kronman; B Velan; Y Gozes; M Leitner; Y Flashner; A Lazar; D Marcus; T Sery; Y Papier; H Grosfeld
Journal:  Gene       Date:  1992-11-16       Impact factor: 3.688

9.  The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant.

Authors:  B Velan; H Grosfeld; C Kronman; M Leitner; Y Gozes; A Lazar; Y Flashner; D Marcus; S Cohen; A Shafferman
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

10.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center.

Authors:  A Shafferman; B Velan; A Ordentlich; C Kronman; H Grosfeld; M Leitner; Y Flashner; S Cohen; D Barak; N Ariel
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

View more
  15 in total

1.  Effects of soman inhibition and of structural differences on cholinesterase molecular dynamics: a neutron scattering study.

Authors:  F Gabel; M Weik; P Masson; F Renault; D Fournier; L Brochier; B P Doctor; A Saxena; I Silman; G Zaccai
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

2.  Effect of human acetylcholinesterase subunit assembly on its circulatory residence.

Authors:  T Chitlaru; C Kronman; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

Review 3.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

4.  Effect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevity.

Authors:  O Cohen; C Kronman; T Chitlaru; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

5.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

Authors:  Oksana Lockridge; Lawrence M Schopfer; Gail Winger; James H Woods
Journal:  J Med Chem Biol Radiol Def       Date:  2005-07-01

6.  Butyrylcholinesterase is complexed with transferrin in chicken serum.

Authors:  E Weitnauer; C Ebert; F Hucho; A Robitzki; C Weise; P G Layer
Journal:  J Protein Chem       Date:  1999-02

7.  Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.

Authors:  Michelle N Ngamelue; Kohei Homma; Oksana Lockridge; Oluwatoyin A Asojo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

8.  Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.

Authors:  T Chitlaru; C Kronman; M Zeevi; M Kam; A Harel; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

9.  Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).

Authors:  Ofer Cohen; Chanoch Kronman; Baruch Velan; Avigdor Shafferman
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

10.  Bovine acetylcholinesterase: cloning, expression and characterization.

Authors:  I Mendelson; C Kronman; N Ariel; A Shafferman; B Velan
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.